0001076167-11-000018.txt : 20110819 0001076167-11-000018.hdr.sgml : 20110819 20110819092205 ACCESSION NUMBER: 0001076167-11-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110809 FILED AS OF DATE: 20110819 DATE AS OF CHANGE: 20110819 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADOLOR CORP CENTRAL INDEX KEY: 0001076167 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311429198 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 MAIL ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maurer George R CENTRAL INDEX KEY: 0001453079 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30039 FILM NUMBER: 111046151 MAIL ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-08-09 0 0001076167 ADOLOR CORP ADLR 0001453079 Maurer George R 700 PENNSYLVANIA DRIVE EXTON PA 19341 0 1 0 0 SVP, Mfg. & Pharm Technologies Common Stock 2011-08-09 4 A 0 13750 0 A 161025 D Represents vesting of performance-based deferred share award upon successful completion of a Phase 2 study of ADL5945 in opioid-induced constipation, pursuant to the terms of a performance-based deferred stock agreement with the Company dated September 9, 2010. /s/ George R. Maurer 2011-08-19